Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

E-cadherin mutation and Snail overexpression as alternative mechanisms of E-cadherin inactivation in synovial sarcoma.

Oncogene - 11 Nov 2004

Saito Tsuyoshi, Oda Yoshinao, Kawaguchi Ken-ichi, Sugimachi Keishi, Yamamoto Hidetaka, Tateishi Naomi, Tanaka Kazuhiro, Matsuda Shuichi, Iwamoto Yukihide, Ladanyi Marc, Tsuneyoshi Masazumi

Abstract excerpt

We have recently reported frequent E-cadherin gene mutations in synovial sarcoma (SS), suggesting mutational inactivation of E-cadherin as a potential mechanism of spindle cell morphology in SS, a spindle cell sarcoma that shows areas of glandular epithelial differentiaton in some cases (biphasic...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cadherins
Share to CpG Islands
Share to DNA Methylation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Gene Expression Regulation, Neoplastic

Share to Oncogene Proteins, Fusion

Share to Proto-Oncogene Proteins

Share to Proto-Oncogene Proteins c-ets

Share to Snail Family Transcription Factors

Source

Identifiers

PMID: 15467754
DOI: 10.1038/sj.onc.1207960

Genes

ELF3
SSX1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026. Prepared record publication-15467754-2026-09-01.1. Manifest publication-graph-cohort-2026-09-01.1.

Source receipt: PubMed via Helena Literature Corpus, retrieved 1 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

E-cadherin mutation and Snail overexpression as alternative mechanisms of E-cadherin inactivation in synovial sarcoma.PMID 15467754Read ↗

E-cadherin gene mutations frequently occur in synovial sarcoma as a determinant of histological features.Semantic proximity Read ↗

SYT-SSX1 and SYT-SSX2 Interfere with Repression of E-Cadherin by Snail and Slug: A Potential Mechanism for Aberrant Mesenchymal to Epithelial Transition in Human Synovial SarcomaSemantic proximity Read ↗

Fusions of the SYT and SSX genes in synovial sarcoma.Semantic proximity Read ↗

<i>SYT–SSX</i> Gene Fusion as a Determinant of Morphology and Prognosis in Synovial SarcomaSemantic proximity Read ↗

The Synovial Sarcoma–Associated SS18-SSX2 Fusion Protein Induces Epigenetic Gene (De)RegulationSemantic proximity Read ↗

Synovial Sarcoma: Recent Discoveries as a Roadmap to New Avenues for TherapySemantic proximity Read ↗

PTEN and other tumor suppressor gene mutations as secondary genetic alterations in synovial sarcoma.Semantic proximity Read ↗

Expression of cadherins and their undercoat proteins (alpha-, beta-, and gamma-catenins and p120) and accumulation of beta-catenin with no gene mutations in synovial sarcoma.Semantic proximity Read ↗

Prognostic value of the preserved expression of the E-cadherin and catenin families of adhesion molecules and of ?-catenin mutations in synovial sarcomaSemantic proximity Read ↗

The SYT-SSX1 variant of synovial sarcoma is associated with a high rate of tumor cell proliferation and poor clinical outcome.Semantic proximity Read ↗

Identification of a novel spliced variant of the SYT gene expressed in normal tissues and in synovial sarcoma.Semantic proximity Read ↗

Targeting the Wnt Pathway in Synovial Sarcoma ModelsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.